Streetbeat News

Stock Prices

PFE

Pfizer (NYSE:PFE) has seen a notable increase in options activity, with a bearish sentiment prevailing among investors. Analysis of 27 trades reveals 29% bullish and 59% bearish positions, with significant activity in puts and calls indicating a price band focus between $15.0 and $32.5. The market's attention on Pfizer's options suggests liquidity and interest at these strike prices. Pfizer, a leading pharmaceutical company with annual sales nearing $50 billion, has its stock price currently up 1.15% at $28.17. Analyst ratings over the past month average a target price of $38.75, with varying opinions from firms like Cantor Fitzgerald and Morgan Stanley.

Portfolio Pulse from Benzinga Insights

May 09, 2024 | 8:46 pm

CARG

CarGurus forecasts Q2 total revenue to be between $202M-$222M, slightly below the estimated $224.504M, with an adjusted EPS of $0.29-$0.34, aligning with the estimated $0.30.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:45 pm

NGVC

Natural Grocers (NGVC) reported a 34.62% increase in Q2 2024 GAAP EPS to $0.35 from $0.26 YoY, with sales rising 8.77% to $308.092M from $283.245M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:45 pm

AMPS

Altus Power (NYSE:AMPS) reported Q1 2024 earnings of $0.05 per share, surpassing the $(0.08) estimate, marking a 162.5% beat and a 66.67% increase from last year's $0.03. Sales reached $40.659M, exceeding the $39.920M estimate by 1.85% and showing a 38.40% increase from the previous year's $29.378M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:45 pm

DNA

Ginkgo Bioworks Holdings (NYSE:DNA) reported Q1 2024 earnings with a GAAP EPS of $(0.08), surpassing the $(0.09) estimate. However, their sales of $38M fell short of the $46.044M estimate, marking a 52.91% decrease from the previous year's $80.702M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:43 pm

HRB

H&R Block's stock price increased following the announcement of their third-quarter financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:43 pm

ACTG

Acacia Research (NASDAQ:ACTG) reported Q1 sales of $24.320 million, surpassing the analyst consensus estimate of $11.000 million by 121.09%. This represents a 64.29% increase over the previous year's sales of $14.803 million.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:42 pm

G

Genpact shares surged following the announcement of its Q1 financial results, which exceeded expectations. The company also increased its forecast for FY24 earnings per share (EPS) and provided Q2 revenue guidance that surpassed analyst estimates.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:42 pm

FIGS

FIGS (NYSE:FIGS) reported Q1 adjusted earnings of $0.01 per share, unchanged YoY, with sales of $119.29M, beating the $117.94M estimate but marking a 0.78% decrease from last year's $120.23M.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:42 pm

SOUN

SoundHound AI Inc (NASDAQ:SOUN) reported Q1 earnings with revenue of $11.6 million, surpassing estimates of $10.104 million and marking a 73% year-over-year increase. The company also beat EPS estimates with an adjusted loss of 7 cents per share against expected 9 cents. Cumulative subscriptions and bookings backlog rose by 80% year-over-year to $682 million. SoundHound ended the quarter with $226 million in cash. The company projects full-year 2024 revenue between $65 million and $77 million, against estimates of $69.49 million. Shares rose 0.4% after hours to $4.75.

Portfolio Pulse from Adam Eckert

May 09, 2024 | 8:41 pm